Pure Global
NCT05952570

Impact of Oral Protein on Nutritional Status and Quality of Life in HD Patients

The Impact of Oral Protein-based Supplements on Nutritional Status and Quality of Life in Hemodialysis Patients
Alexandria University·ClinicalTrials.gov·dietary supplementNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hemodialysis Complication
Drug/Device/Intervention
oral protein nutritional supplement (Fresubin protein powder)
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Alexandria University
Location
Alexandria, Egypt
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2023
End date
Dec 15, 2023
Enrollment
100 participants
Primary outcome

effect on nutritional status,effect on quality of life

Summary

The aim of this work is to study the effects of oral protein-based supplements on nutritional
 status in hemodialysis patients

ICD-10 classifications
Kidney dialysisOther dialysisCare involving dialysisMechanical complication of vascular dialysis catheterHaemoglobinuria due to haemolysis from other external causes
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05952570
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05952570 through Pure Global AI's free database. This phase not specified trial is sponsored by Alexandria University and is currently Not yet recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.